{"schema_version":"secwatch.filing_event.v1","accession":"0000927066-22-000110","form_type":"8-K","ticker":"DVA","cik":"0000927066","company_name":"DAVITA INC.","filed_at":"2022-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.454905+00:00","generated_at":"2026-06-25T07:01:57.922077+00:00","sec_items":["7.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"DaVita and Medtronic form joint venture to create independent kidney-care device company","bullets":["Equal equity stakes; Medtronic contributes Renal Care Solutions; DaVita pays $75M cash and $25M other assets.","Each contributes $200M cash to launch NewCo; up to $300M milestone payments possible through 2028.","Expected close in 2023, subject to HSR and other regulatory approvals.","DaVita expects quarterly charges ~$20M after close, decreasing to zero in 2-3 years as NewCo reaches breakeven.","Independent management and six-person board with two directors from each parent plus two independents."],"urls":{"canonical":"https://secwatch.observer/filing/0000927066-22-000110","json":"https://secwatch.observer/filing/0000927066-22-000110.json","markdown":"https://secwatch.observer/filing/0000927066-22-000110.md","text":"https://secwatch.observer/filing/0000927066-22-000110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927066/000092706622000110/0000927066-22-000110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927066/000092706622000110/dva-20220525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T07:01:57.922077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}